Cefpodoxime

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Half-life
This section has been translated automatically.

2–3 h

Spectrum of action
This section has been translated automatically.

Branhamella catarrhalis, Brucella spp., Corynebacterium diphtheriae, Citrobacter spp., Enterobacter spp., E. coli, Hafnia alvei, Haemophilus spp., Klebsiella spp, Morganella morganii, Neisseria spp., Pasteurella multocida, Proteus spp., Providentia spp., Salmonella spp., Shigella spp., Staphylococcus spp., Streptococcus spp., Yersinia enterocolica

Ineffective against enterococci, only weakly effective against staphylococcus.

Indication
This section has been translated automatically.

Respiratory, urinary tract, skin and soft tissue infections.

Dosage and method of use
This section has been translated automatically.

  • 2 times 100-200 mg/day p.o.
  • Children from 4th week: 5-12 mg/kg bw/day in 2 doses (juice).

Preparations
This section has been translated automatically.

Orelox, Podomexef

Outgoing links (1)

Cephalosporins;

Authors

Last updated on: 29.10.2020